Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

257
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
257
Connective Tissue Cell Types01:22

Connective Tissue Cell Types

3.8K
Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
3.8K
Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

6.9K
The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
6.9K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

308
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
308
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

199
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
199
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

531
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
531

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artificial intelligence adoption in healthcare: a systematic review of implementation challenges and health services implications.

BMC health services research·2026
Same author

Personalized Hemodialysis Approaches in Frail Older Individuals.

Geriatrics (Basel, Switzerland)·2026
Same author

Pharmaceutical Strategies for West Nile Virus in Europe, an Underrecognized Cause of Severe Disease and Mortality in Older Adults: From Supportive Care to Antiviral Development.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Planetary Health Diet Adherence and Medication Use in Older Adults with Chronic Kidney Disease: A Cross-Sectional Study.

Geriatrics (Basel, Switzerland)·2026
Same author

Author Correction: Exome analysis links kidney malformations to developmental disorders and reveals causal genes.

Nature communications·2025
Same author

New prognostic markers for IgA nephropathy in children.

Pediatric nephrology (Berlin, Germany)·2025

Related Experiment Video

Updated: Nov 15, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.8K

Vitamin D and Glomerulonephritis.

Guido Gembillo1,2, Rossella Siligato1, Michela Amatruda3

  • 1Unit of Nephrology and Dialysis, Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy.

Medicina (Kaunas, Lithuania)
|March 6, 2021
PubMed
Summary
This summary is machine-generated.

Vitamin D plays a crucial role in kidney health, particularly in Glomerulonephritis (GN). Supplementation can reduce proteinuria and inflammation, preserving podocyte function and slowing disease progression in GN patients.

Keywords:
CKDVDRcalcitriolglomerular diseaseglomerulonephritisparicalcitolvitamin D

More Related Videos

Assessment of Kidney Function in Mouse Models of Glomerular Disease
09:16

Assessment of Kidney Function in Mouse Models of Glomerular Disease

Published on: June 30, 2018

18.2K
Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
09:16

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis

Published on: June 18, 2020

7.1K

Related Experiment Videos

Last Updated: Nov 15, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.8K
Assessment of Kidney Function in Mouse Models of Glomerular Disease
09:16

Assessment of Kidney Function in Mouse Models of Glomerular Disease

Published on: June 30, 2018

18.2K
Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
09:16

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis

Published on: June 18, 2020

7.1K

Area of Science:

  • Nephrology
  • Endocrinology
  • Immunology

Background:

  • Vitamin D has functions beyond bone health, including regulating the Renin-Angiotensin-Aldosterone System (RAAS) and erythropoiesis.
  • Vitamin D function is impaired in Chronic Kidney Disease (CKD) due to reduced renal 1α-hydroxylase activity and altered Vitamin D-binding protein (DBP) levels.
  • In Glomerulonephritis (GN), Vitamin D supplementation shows promise in reducing proteinuria and inflammation.

Purpose of the Study:

  • To elucidate the role of Vitamin D in immunomodulation, inflammation, and autoimmune processes in Glomerulonephritis (GN).
  • To explore the therapeutic potential of various Vitamin D analogs in managing GN.

Main Methods:

  • Review of existing literature on Vitamin D's functions and its impact on kidney disease.
  • Analysis of Vitamin D supplementation's effects on proteinuria, inflammation, and podocyte integrity in GN models.
  • Comparison of different activated Vitamin D analogs (e.g., calcitriol, maxacalcitol, doxercalciferol, paricalcitol) for their efficacy and safety profiles in GN.

Main Results:

  • Vitamin D supplementation significantly reduces proteinuria and slows kidney disease progression in GN.
  • Activated Vitamin D analogs preserve podocyte structure and function by modulating key proteins and receptors.
  • Certain analogs like paricalcitol effectively suppress RAAS gene expression, reducing proteinuria and renal damage with a lower risk of hypercalcemia.

Conclusions:

  • Vitamin D plays a vital role in managing Glomerulonephritis through its immunomodulatory and anti-inflammatory effects.
  • Activated Vitamin D and its analogs are promising therapeutic agents for GN, offering benefits in reducing proteinuria and preserving kidney function.
  • Further research into specific Vitamin D analogs may lead to improved treatment strategies for GN patients.